Bringing Digital Pathology to Life
Aperio Launches Professional Services
Dedicated Team Provides Valuable, Full-Service Solutions to Digital Pathology Customers
Vista, CA – February 20, 2008 - Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, is pleased to announce the launch of its Professional Services offering, supported by a newly created dedicated team, to help customers achieve their unique digital pathology objectives.
"The creation of a Professional Services offering is a key milestone for Aperio, and places our company at the forefront in offering a full range of value-added services to complement our market-leading digital pathology systems,” stated Dirk Soenksen, CEO of Aperio. "Our dedicated Professional Services team continues Aperio’s commitment to helping customers derive maximum value and a superior experience from our digital pathology solutions."
The Professional Services portfolio is organized into three key capabilities: IT Services, Configuration Services, and Compliance Services, each focused on providing customer-differentiated solutions to facilitate increased system utility and customer satisfaction. In addition, Aperio will provide comprehensive, enterprise-level training and support to ensure continued customer success.
To learn more about Aperio’s professional service capabilities for digital pathology implementations, contact services@aperio.com or call 866.478.4111.
About Aperio Technologies
Aperio is digitizing pathology. We provide systems and services for digital pathology, which is an environment for the management and interpretation of pathology information that originates with the digitization of a glass slide. Aperio’s award-winning ScanScope® slide scanning systems and Spectrum™ digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research, and image analysis. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For more information, please visit www.aperio.com.
Kevin Whiteley
Vice President, Marketing
Aperio
760.539.1177
kwhiteley@aperio.com
Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com
